Product
Olmesartan medoxomil + chlorthalidone
1 clinical trial
1 indication
Indication
HypertensionClinical trial
Efficacy and Safety Evaluation of the New Association on Fixed Dose of Olmesartan Medoxomil + Chlorthalidone (40mg + 12.5mg and 40mg + 25mg) Compared With BENICAR HCT® in Hypertension ControlStatus: Not yet recruiting, Estimated PCD: 2025-06-01